Literature DB >> 28746778

Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours.

Masayo Yoshimura1, Yoshiaki Kinoshita1, Makoto Hamasaki1, Shinji Matsumoto1, Tomoyuki Hida2, Yoshinao Oda2, Kazuki Nabeshima1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28746778     DOI： 10.1111/his.13321

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  3 in total

1.  Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.

Authors:  Yoshiaki Kinoshita; Makoto Hamasaki; Masayo Yoshimura; Shinji Matsumoto; Akinori Iwasaki; Kazuki Nabeshima
Journal:  Mod Pathol       Date:  2019-06-23       Impact factor: 7.842

2.  Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma.

Authors:  Lucian R Chirieac; Yin P Hung; Assunta De Rienzo; David T Severson; Samuel Freyaldenhoven; Corinne E Gustafson; Nhien T Dao; Claire V Meyerovitz; Michela E Oster; Roderick V Jensen; Beow Y Yeap; Raphael Bueno; William G Richards
Journal:  J Pathol       Date:  2020-10-15       Impact factor: 7.996

Review 3.  Application of immunohistochemistry in diagnosis and management of malignant mesothelioma.

Authors:  David B Chapel; Jefree J Schulte; Aliya N Husain; Thomas Krausz
Journal:  Transl Lung Cancer Res       Date:  2020-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.